Search Within

Maria C Pietanza

Formats
  1. Meeting Abstract (67)
  2. Journal Article (50)
  3. Book Section (4)
  4. Correspondence (1)
Groups
  1. Department of Medicine (84)
  2. Solid Tumor Oncology Division (81)
  3. Thoracic Oncology (75)
  4. Department of Pathology and Laboratory Medicine (50)
  5. GSK Faculty (48)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (37)

More Groups

People
  1. Mark Kris (50)
  2. Lee Krug (37)
  3. Charles Rudin (33)
  4. William Travis (33)
  5. Gregory Riely (27)
  6. Natasha Rekhtman (24)

More People

Years
  1. 2019 (2)
  2. 2018 (2)
  3. 2017 (8)
  4. 2016 (16)
  5. 2015 (24)
  6. 2014 (15)

More Years

Publications
  1. Journal of Clinical Oncology (29)
  2. Journal of Thoracic Oncology (26)
  3. Modern Pathology (8)
  4. International Journal of Radiation Oncology, Biology, Physics (6)
  5. Laboratory Investigation (6)
  6. Annals of Oncology (4)

More Publications

Publishers
  1. Elsevier Inc. (39)
  2. American Society of Clinical Oncology (29)
  3. Nature Publishing Group (8)
  4. Nature Research (8)
  5. Oxford University Press (6)
  6. American Association for Cancer Research (5)

More Publishers

Results (122)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety, activity, and response durability assessment of single agent rovalpituzumab tesirine, a delta-like protein 3 (DLL3)-targeted antibody drug conjugate (ADC), in small cell lung cancer (SCLC)
    Meeting Abstract

    Pietanza, M. C.; Spigel, D.; Bauer, T. M.; Ready, N. E.; Glisson, B. S.; Morgensztern, D.; Robert, F.; Salgia, R.; Kochendorfer, M.; Patel, M.; more...
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • Nivolumab (NIVO) monotherapy or in combination with ipilimumab (IPI) for treatment of recurrent small cell lung cancer (SCLC)
    Meeting Abstract

    Calvo, E.; Lopez-Martin, J. A.; Bendell, J.; Eder, J. P.; Taylor, M.; Ott, P. A.; Pietanza, M. C.; Horn, L.; Jäger, D.; De Braud, F.; more...
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo
    Journal Article

    Saunders, L. R.; Bankovich, A. J.; Anderson, W. C.; Aujay, M. A.; Bheddah, S.; Black, K.; Desai, R.; Escarpe, P. A.; Hampl, J.; Laysang, A.; more...
    Science Translational Medicine (2015)

    Fulltext@MSK | Save
  • Small cell lung cancer: Will recent progress lead to improved outcomes?
    Journal Article

    Pietanza, M. C.; Byers, L. A.; Minna, J. D.; Rudin, C. M.
    Clinical Cancer Research (2015)

    Fulltext@MSK | Save
  • A phase 1 study of crizotinib and ganetespib (STA-9090) in ALK positive lung cancers
    Meeting Abstract

    Riely, G. J.; Yu, H. A.; Stephens, D.; Pietanza, M. C.; Smith-Marrone, S.; Fiore, J. J.; Goldstein, M.; Sima, C. S.; Kris, M. G.; Ginsberg, M. S.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Prospective molecular analysis of small cell lung cancer (SCLC) using next generation sequencing (NGS)
    Meeting Abstract

    Pietanza, M. C.; Won, H. H.; Rekhtman, N.; Wang, L.; Travis, W. D.; Krug, L. M.; Varghese, A. M.; Paik, P. K.; Riely, G. J.; Zakowski, M. F.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Final results of phase Ib of tarextumab (TRXT, OMP-59R5, anti-Notch2/3) in combination with etoposide and platinum (EP) in patients (pts) with untreated extensive-stage small-cell lung cancer (ED-SCLC)
    Meeting Abstract

    Pietanza, M. C.; Spira, A. I.; Jotte, R. M.; Gadgeel, S. M.; Mita, A. C.; Hart, L. L.; Gluck, W. L.; Chiang, A. C.; Liu, S. V.; Kapoun, A. M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Defining the immunologic phenotype of thymic epithelial tumors
    Meeting Abstract

    Naidoo, J.; Steele, K.; Sima, C. S.; Yuan, J. D.; Robbins, P. B.; Moreira, A. L.; Pietanza, M. C.; Wolchok, J. D.; Riely, G. J.; Rizvi, N. A.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase II trial of bortezomib in KRAS G12D mutant lung cancers
    Meeting Abstract

    Litvak, A. M.; Drilon, A. E.; Rekhtman, N.; Pietanza, M. C.; Chaft, J. E.; Woo, K.; Paik, P. K.; Kris, M. G.; Riely, G. J.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase I/II study of nivolumab with or without ipilimumab for treatment of recurrent small cell lung cancer (SCLC): CA209-032
    Meeting Abstract

    Antonia, S. J.; Bendell, J. C.; Taylor, M. H.; Calvo, E.; Jaeger, D.; De Braud, F. G.; Ott, P. A.; Pietanza, M. C.; Horn, L.; Le, D. T.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save